- Email: [email protected]
New Editor of Molecular Therapy
COMMENTARY
doi:10.1006/mthe.2002.0685, available online at http://www.idealibrary.com on IDEAL
New Editor of Molecular Therapy –Inder M. Verma, Editor-in-Chief
R
obert (Rob) Murray Frederickson has been appointed the Managing Editor of Molecular Therapy starting August 26, 2002. He will take over the responsibilities previously carried out by Fintan Steele. Rob obtained his Ph.D. in Biochemistry and Cell Biology in 1994 from McGill University in Montreal, Canada. He then joined Nature magazine as an assistant biology editor. From 1996 to 1998 Rob worked in the laboratory of Stan Fields at the University of Washington in Seattle as a postdoctoral fellow. In 1998 Rob rejoined the Nature group, first as Research Editor for Nature Biotechnology and then as Senior Editor at Nature Medicine. In November 2000, Rob was appointed the Editor and Director of Content Development of the biotechnology web portal Bio.com, based in Berkeley, California. He most recently was the Editorial Manager at LifeSpan Biosciences in Seattle. Rob is also a freelance writer for the Elsevier journal Chemistry and Biology. Rob is fluent in English and French and brings substantial experience in scientific publication. Rob will be based at Elsevier’s offices in San Diego, California. The staff of Elsevier, the editorial board of Molecular Therapy, and the members of the American Society of Gene Therapy extend Rob Frederickson a very warm welcome!
(Please continue to submit manuscripts to the New York office.)
300
MOLECULAR THERAPY Vol. 6, No. 3, September 2002 Copyright © The American Society of Gene Therapy
doi:10.1006/mthe.2002.0685, available online at http://www.idealibrary.com on IDEAL
New Editor of Molecular Therapy –Inder M. Verma, Editor-in-Chief
R
obert (Rob) Murray Frederickson has been appointed the Managing Editor of Molecular Therapy starting August 26, 2002. He will take over the responsibilities previously carried out by Fintan Steele. Rob obtained his Ph.D. in Biochemistry and Cell Biology in 1994 from McGill University in Montreal, Canada. He then joined Nature magazine as an assistant biology editor. From 1996 to 1998 Rob worked in the laboratory of Stan Fields at the University of Washington in Seattle as a postdoctoral fellow. In 1998 Rob rejoined the Nature group, first as Research Editor for Nature Biotechnology and then as Senior Editor at Nature Medicine. In November 2000, Rob was appointed the Editor and Director of Content Development of the biotechnology web portal Bio.com, based in Berkeley, California. He most recently was the Editorial Manager at LifeSpan Biosciences in Seattle. Rob is also a freelance writer for the Elsevier journal Chemistry and Biology. Rob is fluent in English and French and brings substantial experience in scientific publication. Rob will be based at Elsevier’s offices in San Diego, California. The staff of Elsevier, the editorial board of Molecular Therapy, and the members of the American Society of Gene Therapy extend Rob Frederickson a very warm welcome!
(Please continue to submit manuscripts to the New York office.)
300
MOLECULAR THERAPY Vol. 6, No. 3, September 2002 Copyright © The American Society of Gene Therapy